FIRMANI LORI (Interim CFO) sold 12.7% of their position (135.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2026ACC: 0001193125-26-004565
Officer· Interim CFO
Since Aug 2024
-135.00
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
374.00 acquired · 509.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+374.00
Price / share
—
Trade value
—
% of position
54.0%
1/2/2026
692.00→1.07K
Common Stock
Direct
Shares
−135.00
Price / share
$21.41
Trade value
$2.89K
% of position
12.7%
1/2/2026
1.07K→931.00
Total
Net shares
+239.00
Net value
-$2.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +374.00 | — | — | 54.0% | 692.00 | 1.07K |
| Common Stock Direct | 1/2/2026 | S · Sale | −135.00 | $21.41 | $2.89K | 12.7% | 1.07K | 931.00 |
| Total | +239.00 | -$2.89K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
374.00 shares
Shares
−374.00
Strike price
Held after
726.00
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock374.00 shares | 1/2/2026 | M · Option Exercise | −374.00 | — | 726.00 |